menu search

Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform

Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
Patients transplanted with trem-cel achieved primary neutrophil engraftment and high levels of myeloid donor chimerism. Strong investigator enthusiasm and continued robust enrollment; additional data updates expected by year-end 2023. U.S. FDA clears VCAR33ALLO IND. Conference call scheduled for today, June 9 at 8:30am ET. CAMBRIDGE, Mass., June 09, 2023 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: […] The post Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of... Read More
Posted: Jun 9 2023, 11:30
Author Name: forextv
Views: 101862

Search within

Pages Search Results: